These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 25392257)

  • 21. Prognostic significance of tumor size in patients with stage III non-small-cell lung cancer: a surveillance, epidemiology, and end results (SEER) survey from 1998 to 2003.
    Morgensztern D; Waqar S; Subramanian J; Gao F; Trinkaus K; Govindan R
    J Thorac Oncol; 2012 Oct; 7(10):1479-84. PubMed ID: 22982648
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preoperative serum carcinoembryonic antigen elevation in stage I colon cancer: improved risk of mortality in stage T1 than in stage T2.
    Shen F; Cui J; Hong X; Yu F; Bao X
    Int J Colorectal Dis; 2019 Jun; 34(6):1095-1104. PubMed ID: 31016378
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increasing the number of lymph nodes examined after colectomy does not improve colon cancer staging.
    Budde CN; Tsikitis VL; Deveney KE; Diggs BS; Lu KC; Herzig DO
    J Am Coll Surg; 2014 May; 218(5):1004-11. PubMed ID: 24661856
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumor subsite location within the colon is prognostic for survival after colon cancer diagnosis.
    Wray CM; Ziogas A; Hinojosa MW; Le H; Stamos MJ; Zell JA
    Dis Colon Rectum; 2009 Aug; 52(8):1359-66. PubMed ID: 19617745
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Survival trends for left and right sided colon cancer using population-based SEER database: A forty-five-year analysis from 1975 to 2019.
    Ulanja MB; Asafo-Agyei KO; Neelam V; Beutler BD; Antwi-Amoabeng D; Governor SB; Rahman GA; Djankpa FT; Ulanja RN; Nteim GB; Mabrouk T; Amankwah M; Alese OB
    Cancer Med; 2024 Apr; 13(8):e7145. PubMed ID: 38651190
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic impact of tumor location in stage IV colon cancer: a propensity score analysis in a multicenter study.
    Ishihara S; Nishikawa T; Tanaka T; Tanaka J; Kiyomatsu T; Kawai K; Hata K; Nozawa H; Kanazawa T; Kazama S; Yamaguchi H; Sunami E; Kitayama J; Hashiguchi Y; Sugihara K; Watanabe T
    Int J Surg; 2014; 12(9):925-30. PubMed ID: 25091400
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nodal status, number of lymph nodes examined, and lymph node ratio: what defines prognosis after resection of colon adenocarcinoma?
    Gleisner AL; Mogal H; Dodson R; Efron J; Gearhart S; Wick E; Lidor A; Herman JM; Pawlik TM
    J Am Coll Surg; 2013 Dec; 217(6):1090-100. PubMed ID: 24045143
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Carcinoma of the uterine cervix. I. Impact of prolongation of overall treatment time and timing of brachytherapy on outcome of radiation therapy.
    Perez CA; Grigsby PW; Castro-Vita H; Lockett MA
    Int J Radiat Oncol Biol Phys; 1995 Jul; 32(5):1275-88. PubMed ID: 7635767
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Population-based outcome of stage IA-IIA resected gastric adenocarcinoma: who should get adjuvant treatment?
    Gold JS; Al Natour RH; Saund MS; Yoon C; Sharma AM; Huang Q; Boosalis VA; Whang EE
    Ann Surg Oncol; 2013 Jul; 20(7):2304-10. PubMed ID: 23344580
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of Adjuvant Chemotherapy on Early-onset Stage II Colon Cancer at Different Tumor Sites.
    Tan C; Wang Q; Yao S
    Am J Clin Oncol; 2024 Jun; 47(6):253-258. PubMed ID: 38251762
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular testing for lymph node metastases as a determinant of colon cancer recurrence: results from a retrospective multicenter study.
    Sargent DJ; Shi Q; Gill S; Louvet C; Everson RB; Kellner U; Clancy TE; Pipas JM; Resnick MB; Meyers MO; Wu TT; Huntsman D; Validire P; Farooq U; Pavey ES; Beaudry G; Haince JF; Fradet Y
    Clin Cancer Res; 2014 Aug; 20(16):4361-9. PubMed ID: 24919572
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Brachytherapy Is Associated With Improved Survival in Inoperable Stage I Endometrial Adenocarcinoma: A Population-Based Analysis.
    Acharya S; Perkins SM; DeWees T; Fischer-Valuck BW; Mutch DG; Powell MA; Schwarz JK; Grigsby PW
    Int J Radiat Oncol Biol Phys; 2015 Nov; 93(3):649-57. PubMed ID: 26461007
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The impact of socioeconomic status on survival in stage III colon cancer patients: A retrospective cohort study using the SEER census-tract dataset.
    Dhahri A; Kaplan J; Naqvi SMH; Brownstein NC; Ntiri SO; Imanirad I; Felder SI; Dineen SP; Sanchez J; Dessureault S; Carballido E; Powers BD
    Cancer Med; 2021 Aug; 10(16):5643-5652. PubMed ID: 34197047
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative analysis of various prognostic nodal factors, adjuvant chemotherapy and survival among stage III colon cancer patients over 65 years: an analysis using surveillance, epidemiology and end results (SEER)-Medicare data.
    Hanna NN; Onukwugha E; Choti MA; Davidoff AJ; Zuckerman IH; Hsu VD; Mullins CD
    Colorectal Dis; 2012 Jan; 14(1):48-55. PubMed ID: 21689262
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lymph node ratio: role in the staging of node-positive colon cancer.
    Wang J; Hassett JM; Dayton MT; Kulaylat MN
    Ann Surg Oncol; 2008 Jun; 15(6):1600-8. PubMed ID: 18327530
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Does the revised International Federation of Gynecology and Obstetrics staging system for endometrial cancer lead to increased discrimination in patient outcomes?
    Cooke EW; Pappas L; Gaffney DK
    Cancer; 2011 Sep; 117(18):4231-7. PubMed ID: 21387282
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lymph node ratio as prognosis factor for colon cancer treated by colorectal surgeons.
    Vaccaro CA; Im V; Rossi GL; Quintana GO; Benati ML; Perez de Arenaza D; Bonadeo FA
    Dis Colon Rectum; 2009 Jul; 52(7):1244-50. PubMed ID: 19571700
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adjuvant chemotherapy benefits on patients with elevated carcinoembryonic antigen in stage IIA colon cancer: a SEER-based analysis.
    Zhou H; Wang S; Cai Z; Qiu E; Chen Q; Rao X; Han S; Li Z
    Int J Colorectal Dis; 2022 Dec; 37(12):2481-2489. PubMed ID: 36334109
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Surveillance for early stages of colon cancer: potentials for optimizing follow-up protocols.
    Gilardoni E; Bernasconi DP; Poli S; Garancini M; Luperto M; Zucchini N; Bovo G; Totis M; Bugatti A; Gianotti L
    World J Surg Oncol; 2015 Aug; 13():260. PubMed ID: 26311420
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic significance of perineural invasion in stage IIA colon cancer.
    Yun JA; Kim HC; Kim SH; Cho YB; Yun SH; Lee WY; Chun HK
    ANZ J Surg; 2016 Dec; 86(12):1007-1013. PubMed ID: 25113398
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.